ghk-cu peptide injection location administration methods Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy ghk-cu sites administration method – ghk-cu injection sites subcutaneous Product

AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily

Pull the plunger back to draw air into the syringe equal to the volume of water you plan to withdraw

doi: 10.1001/jama.2010.490

Scheduled repeat testing enables clinicians to tailor doses or swap peptides